Jasper Hellweg
Stock Analyst at Argus Research
(3.71)
# 860
Out of 4,413 analysts
52
Total ratings
53.12%
Success rate
5.99%
Average return
Main Sectors:
24 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVO Novo Nordisk | Maintains: Buy | $115 → $125 | $129.21 | -3.26% | 1 | Feb 1, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $825 → $920 | $903.48 | +1.83% | 4 | Sep 15, 2023 | |
| MRNA Moderna | Maintains: Buy | $160 → $140 | $111.46 | +25.61% | 4 | Sep 13, 2023 | |
| MDRX Veradigm | Downgrades: Hold | n/a | $7.82 | - | 2 | Jul 6, 2023 | |
| AZN AstraZeneca | Maintains: Buy | $85 → $80 | $76.41 | +4.70% | 2 | May 26, 2023 | |
| BIIB Biogen | Maintains: Buy | $320 → $350 | $216.13 | +61.94% | 3 | May 11, 2023 | |
| UTHR United Therapeutics | Maintains: Buy | $300 → $280 | $255.14 | +9.74% | 3 | Apr 21, 2023 | |
| ABBV AbbVie | Downgrades: Hold | n/a | $161.72 | - | 2 | Apr 5, 2023 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $340 → $350 | $402.14 | -12.97% | 3 | Mar 29, 2023 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $50.03 | +19.93% | 1 | Mar 27, 2023 | |
| ILMN Illumina | Downgrades: Hold | n/a | $124.68 | - | 3 | Jan 25, 2023 | |
| ZTS Zoetis | Maintains: Buy | $225 → $200 | $158.50 | +26.18% | 3 | Jun 17, 2022 | |
| TEVA Teva Pharmaceutical | Downgrades: Hold | n/a | $13.98 | - | 1 | Jan 27, 2022 | |
| IQV IQVIA Holdings | Maintains: Buy | n/a | $232.94 | - | 4 | Sep 10, 2021 | |
| ITGR Integer Holdings | Upgrades: Buy | n/a | $109.78 | - | 1 | Jun 9, 2021 | |
| LH Laboratory Corporation of America Holdings | Maintains: Buy | n/a | $201.32 | - | 3 | May 20, 2021 | |
| EBS Emergent BioSolutions | Downgrades: Hold | n/a | $1.93 | - | 1 | May 5, 2021 | |
| DGX Quest Diagnostics | Upgrades: Buy | n/a | $137.55 | - | 1 | Oct 21, 2020 | |
| BAX Baxter International | Downgrades: Hold | n/a | $40.34 | - | 1 | Sep 4, 2020 | |
| PRGO Perrigo Company | Downgrades: Hold | n/a | $32.90 | - | 1 | Apr 17, 2020 | |
| EFX Equifax | Downgrades: Hold | n/a | $220.67 | - | 3 | Apr 6, 2020 | |
| LGND Ligand Pharmaceuticals | Downgrades: Hold | n/a | $71.42 | - | 1 | Mar 24, 2020 | |
| HCA HCA Healthcare | Maintains: Buy | n/a | $309.44 | - | 2 | Nov 6, 2018 | |
| MAN ManpowerGroup | Maintains: Buy | n/a | $75.17 | - | 2 | Oct 22, 2018 |
Novo Nordisk
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $129.21
Upside: -3.26%
Regeneron Pharmaceuticals
Sep 15, 2023
Maintains: Buy
Price Target: $825 → $920
Current: $903.48
Upside: +1.83%
Moderna
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $111.46
Upside: +25.61%
Veradigm
Jul 6, 2023
Downgrades: Hold
Price Target: n/a
Current: $7.82
Upside: -
AstraZeneca
May 26, 2023
Maintains: Buy
Price Target: $85 → $80
Current: $76.41
Upside: +4.70%
Biogen
May 11, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $216.13
Upside: +61.94%
United Therapeutics
Apr 21, 2023
Maintains: Buy
Price Target: $300 → $280
Current: $255.14
Upside: +9.74%
AbbVie
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $161.72
Upside: -
Vertex Pharmaceuticals
Mar 29, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $402.14
Upside: -12.97%
Sanofi
Mar 27, 2023
Maintains: Buy
Price Target: $55 → $60
Current: $50.03
Upside: +19.93%
Illumina
Jan 25, 2023
Downgrades: Hold
Price Target: n/a
Current: $124.68
Upside: -
Zoetis
Jun 17, 2022
Maintains: Buy
Price Target: $225 → $200
Current: $158.50
Upside: +26.18%
Teva Pharmaceutical
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $13.98
Upside: -
IQVIA Holdings
Sep 10, 2021
Maintains: Buy
Price Target: n/a
Current: $232.94
Upside: -
Integer Holdings
Jun 9, 2021
Upgrades: Buy
Price Target: n/a
Current: $109.78
Upside: -
Laboratory Corporation of America Holdings
May 20, 2021
Maintains: Buy
Price Target: n/a
Current: $201.32
Upside: -
Emergent BioSolutions
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.93
Upside: -
Quest Diagnostics
Oct 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $137.55
Upside: -
Baxter International
Sep 4, 2020
Downgrades: Hold
Price Target: n/a
Current: $40.34
Upside: -
Perrigo Company
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $32.90
Upside: -
Equifax
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $220.67
Upside: -
Ligand Pharmaceuticals
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $71.42
Upside: -
HCA Healthcare
Nov 6, 2018
Maintains: Buy
Price Target: n/a
Current: $309.44
Upside: -
ManpowerGroup
Oct 22, 2018
Maintains: Buy
Price Target: n/a
Current: $75.17
Upside: -